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The slit diaphragm and the apical and basal membrane
domains of podocytes are connected to each other by an
actin-based cytoskeleton critical to the maintenance of the
glomerular filtration barrier. In an effort to discover novel
regulatory proteins of the podocyte foot process, we
identified and characterized pdlim2, a member
of the actin-associated LIM protein subfamily of cytosolic
proteins typified by an N-terminal PDZ domain and
a C-terminal LIM domain. In the kidney, the pdlim2 protein is
highly specific for the glomerulus and podocyte foot
processes as shown by RT-PCR, western blotting,
immunofluorescence, and immunoelectron microscopy. In
cultured podocytes, pdlim2 was associated with stress fibers
and cortical actin. Pdlim2 seems to regulate actin dynamics in
podocytes since stress fibers were stabilized in its presence.
Mechanistically, pdlim2 interacts with two actin-associated
podocyte proteins, a-actinin-4 and angiomotin-like-1, as
shown by immunoprecipitation and yeast two-hybrid
analyses. By semi-quantitative immunoelectron microscopy,
there was a reduced expression of pdlim2 in podocytes of
patients with minimal change nephrotic syndrome and
membranous nephropathy, whereas its expression was
unchanged in patients with focal segmental
glomerulosclerosis. Hence, pdlim2 is a novel actin-regulating
protein of podocyte foot processes that may have a role in
the pathogenesis of glomerular diseases.
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The podocyte is a key factor in the glomerular filtration
function.1 Morphologically, podocytes can be divided into a
cell body, major processes, and distal foot processes. Podocyte
foot processes are connected to each other by cell–cell
junctions called slit diaphragms.2 This junction divides the
plasma membrane into three parts, namely the slit
diaphragm, the basal domain, and the apical domain. The
slit diaphragm is perhaps the most critical component of the
glomerular filter as defects in most molecular components of
this structure result in proteinuric disease.3 The connection
between the slit diaphragm and the actin cytoskeleton is also
essential for the filtration barrier as absence of linker proteins
nck and cd2-associated protein result in proteinuria.4,5 In
addition, the basal domain of podocytes is important for the
filtration barrier as defects in integrin-mediated podocyte
and glomerular basement membrane adhesion result in
proteinuria.6 The essential role of the apical membrane
domain is highlighted by studies in mice lacking the apical
protein podocalyxin, as these mice display abnormal
podocyte morphology.7
The slit diaphragm, the apical membrane, and the basal
membrane domains are connected to each other by an actin-
based cytoskeleton. Normally, this cytoskeleton is organized
as highly ordered bundles of parallel actin filament. However,
defects in any of the three membrane domains can lead to a
reorganization of the actin cytoskeleton and transformation
into a dense network.8 This is observed as foot process
effacement, an ultrastructural finding generally associated
with proteinuria. On the other hand, studies on actin-
regulating proteins a-actinin-4 and synaptopodin have
shown that the impaired regulation of actin assembly in
foot processes results in proteinuric renal disease.9,10 Taken
together, it is clear that understanding the mechanisms
governing organization of the foot process actin cytoskeleton
in normal and pathological states is of critical importance.
In this study, we have identified pdlim2 as a novel
molecular component of podocyte foot processes. Pdlim2
seems to be involved in regulating actin dynamics as
podocyte stress fibers are more stabile in the presence of
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pdlim2 and because pdlim2 interacts with podocyte proteins
a-actinin-4 and angiomotin-like-1 (amotl1), two known
regulators of actin assembly.11,12
RESULTS
Pdlim2 is expressed by glomerular tufts
The presence of pdlim2 transcript in the kidney glomerulus
was confirmed by reverse transcriptase-PCR, as the pdlim2-
specific product from both the glomerular fraction and
the kidney portion devoid of glomeruli was amplified
(Figure 1a). The signal for pdlim2 was clearly stronger in
the glomerulus, which is in line with our previous microarray
data.13 Similar signal pattern was observed for a known
podocyte-specific transcript podocin. The control reverse
transcriptase-PCR experiment using GAPDH (glyceraldehyde
3-phosphate dehydrogenase) primers produced a strong
signal in both fractions.
We raised a rabbit polyclonal antibody directed against the
human pdlim2 protein residues 87–212. We tested the
specificity of the antibody by transfecting HEK293 with
pdlim2 and nephrin (control) constructs. Western blotting
using anti-pdlim2 antibody showed an expected B40 kD
protein in pdlim2-transfected cells, whereas no reactivity was
detected in nephrin-transfected cells (Supplementary
Figure S1a online). A smaller protein, representing perhaps
a modified form of pdlim2, was also detected in pdlim2-
transfected cells. Western blotting with anti-nephrin antibody
showed an expectedB185 kD protein in nephrin-transfected
cells, whereas no immunoreactivity was detected in pdlim2-
transfected cells. In a lysate prepared from lung, a tissue
previously shown to express pdlim2,14 anti-pdlim2 antibody
recognized a B40 kD protein. Immunofluorescence staining
with anti-pdlim2 antibody gave strong reactivity in pdlim2-
transfected cells, whereas no signal was detected in nephrin-
transfected cells (Supplementary Figures S1b and c online).
Furthermore, staining for nephrin was observed in nephrin
but not in pdlim2-transfected cells (Supplementary Figures
S1d and e online). Taken together, the antibody generated
seemed to react specifically with pdlim2.
In western blotting of human kidney lysates, the anti-
pdlim2 antibody recognized a B40 kD protein in the
glomerular fraction (Figure 1b). The size of this protein is
in line with the predicted molecular weight of pdlim2 (NCBI
(National Center for Biotechnology Information) Reference
Sequence: NP_789847.1). In the kidney fraction lacking
glomeruli, no pdlim2 was detected (Figure 1b). Western
blotting for a known podocyte-specific protein nephrin was
detected similarly only in the glomerular fraction (Figure 1b).
b-Actin, used as a loading control, was detected in both lanes.
Localization of the pdlim2 protein in the glomerulus
Immunofluorescence staining with the anti-pdlim2 antibody
gave intense reactivity in glomeruli (Figure 1c). No positive
signal was detected outside glomeruli. In the glomerulus, a
strong linear staining was found around glomerular capil-
laries (Figure 2a). Double stainings with synaptopodin
showed that pdlim2 colocalized with this foot process marker
(Figure 2a–f). Double labeling with phalloidin (detecting
actin) also demonstrated colocalization in foot processes
(Figure 2g–i). Double staining with vimentin, a marker for
major processes of podocytes, showed no overlapping
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Figure 1 | Expression of pdlim2 in the kidney by reverse
transcriptase-PCR (RT-PCR), western blotting (WB), and
immunofluorescence staining. (a) By RT-PCR, a strong band
sizedB1100 bp is detected in the glomerulus fraction, whereas a
much weaker PCR product is amplified from the rest of the kidney
fraction (lacking glomeruli). The size of the PCR product is in line
with the expected fragment size (1098 bp). The control PCR with
podocin primers gives a similar expression pattern for this known
podocyte-specific protein, whereas glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) primers give strong signal in both renal
fractions. (b) In western blotting, the affinity-purified anti-pdlim2
antibody recognizes a protein sized B40 kDa in the glomerular
fraction. No immunoreactivity for pdlim2 was detected in the
kidney fraction lacking glomeruli. Anti-nephrin antibody gives an
expected bandB185 kDa in the glomerulus fraction. The loading
control with b-actin antibody recognizes an expected protein
sized B40 kDa in both renal fractions. (c) In immunofluorescence
staining of adult human kidney sections, a strong reactivity
for pdlim2 is detected in glomeruli. No immunoreactivity for
pdlim2 is detected outside glomeruli in the kidney. Original
magnification  50.
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reactivity as vimentin was localized on the side of the urinary
space of pdlim2 (Figure 2j–l).
In immunoelectron microscopy, the label for pdlim2 was
detected in podocyte foot processes (Figure 3a–c). The
labeling was very specific for podocytes as 98% (168/172)
of glomerular gold particles were found in podocytes. Of the
gold labeling in foot and major processes, B95% (1010/
1063) was found in foot processes, indicating that pdlim2 was
highly restricted to these distal processes. In foot processes,
the labeling for pdlim2 was not concentrated to any plasma
membrane domains as only B15% (859/1008) of the foot
process gold labeling was localized o100 nm from the
plasma membrane. Instead, gold labels for pdlim2 seemed
to be concentrated more to the central, electron-dense parts
of foot processes, suggesting an association with actin
filaments (Figure 3b). To confirm this association, we double
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Figure 2 | Expression of pdlim2 in the glomerulus by double immunofluorescence labeling and 4,6-diamidino-2-phenylindole
(DAPI) staining. (a) Staining for pdlim2 (green) is observed as a strong linear reactivity around capillary loops. (a–f) Double labeling with the
foot process marker synaptopodin (red) shows nearly complete overlapping (yellow) distribution of these two proteins in the glomerulus.
(g–i) Double labeling with phalloidin (binding to actin, red) shows overlapping reactivity (yellow) with pdlim2 (green) in peripheral capillary
loops. (j–l) Double labeling with vimentin (marker for major processes, red) does not show overlapping reactivity with pdlim2. Staining for
pdlim2 is located at the capillary side of vimentin immunoreactivity. CS, capillary space; US, urinary space. Original magnifications:  400
(a–c) and  2000 (d–l).
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labeled pdlim2 with synaptopodin, a known actin-associated
protein of foot processes. This experiment demonstrated a
close localization of these two proteins at the electron
microscopic level (Figure 3c). Taken together, in the kidney,
pdlim2 protein was exclusively localized to podocyte foot
processes in which it showed close association to actin
cytoskeleton.
Pdlim2 in cultured podocytes
Using western blotting and immunofluorescence staining, we
did not detect any significant immunoreactivity for pdlim2 in
two well-characterized podocyte cell lines (Supplementary
Figure S2a–d online, data not shown).15,16 Therefore, we
transfected differentiated human podocytes16 with flag-
tagged full-length pdlim2 (f-pdlim2). F-pdlim2 was detected
in stress fibers as indicated by colocalization with phalloidin
staining (Figure 4a–c). In addition, f-pdlim2 was occasionally
colocalizing with phalloidin in the cell periphery (data not
shown), suggesting that pdlim2 associates with cortical actin.
No reactivity for f-pdlim2 was detected in untransfected
podocytes (Figure 4d–f). To further investigate the associa-
tion of pdlim2 with stress fibers, we disrupted the actin
cytoskeleton by incubating podocytes in 5mmol/l latrunculin
A, an actin monomer-sequestering drug. Treatment with
5 mmol/l latrunculin A resulted in a disruption of stress fibers
and retracted cell morphology (Figure 4g–i). In these cells,
actin and pdlim2 colocalized as clusters in the cytoplasm,
supporting the idea that pdlim2 associates with actin.
Pdlim2 stabilizes stress fibers in podocytes
As pdlim2 associated with actin in podocytes, we analyzed
whether pdlim2 was involved in the regulation of the
cytoskeleton assembly. This was performed by comparing
actin-based stress fibers in pdlim2-expressing podocytes with
those in pdlim2-negative cells. The amount and thickness of
the stress fibers in pdlim2-positive cells was unchanged in
comparison with pdlim2-negative cells (data not shown). The
involvement of pdlim2 in the turnover of actin stress fibers
was investigated by treating cultured podocytes with
latrunculin A. When podocytes were incubated in 1mmol/l
latrunculin A, most podocytes, both pdlim2-positive and
pdlim2-negative, had intact stress fibers (Table 1). However,
the proportion of cells with intact stress fibers was
significantly higher in pdlim2-expressing cells (Figure 4j–l
and Table 1). When the concentration of latrunculin A was
increased to 3 mmol/l, the difference between pdlim2-positive
and pdlim2-negative cells became even more apparent.
Although almost half of pdlim2-expressing cells had
detectable stress fibers, only B15% of pdlim2-negative cells
had remaining stress fibers (Table 1). After the incubation of
podocytes in 5mmol/l latrunculin A, only a very small
proportion of cells had remaining stress fibers in both groups
(Table 1). The loss of stress fibers was associated with
significant changes in cell morphology (Figure 4g–i). The
effect of pdlim2 on stress fibers was even more prominent in
undifferentiated podocytes (Supplementary Table S1 online).
Thus, pdlim2 stabilized actin structures in podocytes and
promoted the maintenance of normal cell morphology under
pathological stimulus. Transfection with pcDNA-nephrin
construct did not affect stress fiber stability (data not shown).
Podocyte cell-matrix adhesion assay
As pdlim2 has been shown to affect the cell-matrix adhesion
in MCF-7 breast carcinoma cells,17 we tested whether pdlim2
had a similar role in podocytes. Differentiated podocytes
were transfected with f-pdlim2 and allowed to attach on
collagen I or fibronectin for 15min, 30min, 60min, or 18 h.
Transfection efficiency was 33.4±2.5% (collagen coating)
and 36.9±3.5 (fibronectin coating) as shown by a proportion
of f-pdlim2-positive cells in wells in which cells were allowed
to attach for 18 h (Supplementary Table S2 online). Pdlim2
did not affect the adhesion of podocytes to matrix as the
proportion of pdlim2-positive cells was not significantly
altered in wells that were allowed to attach for 15, 30, or
60min in comparison with control wells (18 h).
GBM
GBM
Figure 3 | Localization of pdlim2 in the glomerulus by
immunoelectron microscopy. (a) Immunogold particles
(arrowheads) marking for pdlim2 are found in podocyte foot
processes. No labeling is observed in major processes. (b) The
labeling is mostly found dispersed in the cytosol of foot processes
with some tendency to cluster in the electron-dense areas, that is,
the cytoskeleton. No concentration of gold particles under the
plasma membrane is observed. (c) Double-labeling experiment
with pdlim2 (10 nm gold) and synaptopodin (5 nm gold,
arrowheads) show that these two proteins are located in close
proximity to each other in foot processes. GBM, glomerular
basement membrane. Scale bar¼ 300 nm (a), 150 nm (b, c).
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Pdlim2 interacts with a-actinin-4 and amotl1
To link pdlim2 to the molecular machinery of foot processes,
we performed the yeast two-hybrid (y2h) screen. The y2h
assay yielded 18 positive clones (Supplementary Table S3
online). Two of these clones encoded for a-actinin-4, a
known component of foot processes. In addition, one of the
clones encoded for amotl1, a protein recently shown to
regulate actin dynamics in cells.12 We analyzed further the
association of a-actinin-4 and amotl1 with pdlim2.
First, we investigated the colocalization of these proteins.
The a-actinin-4 is a known component of podocyte foot
processes and stress fibers; that is, same structures in
F-pdlim2 Phalloidin Merged
Figure 4 |Pdlim2 in cultured podocytes. (a–c) Full-length flag-pdlim2 (f-pdlim2) is targeted to stress fibers in differentiated podocytes
as the immunoreactivity for flag (green) colocalizes (yellow) with phalloidin staining (red) in filamentous intracellular structures.
(d–f) Untransfected podocytes do not show immunoreactivity for f-pdlim2. (g–i) Addition of latrunculin A to cell culture media results in
disruption of stress fibers, and actin is found as cytosolic aggregates. F-pdlim2 colocalizes (yellow) with actin in these aggregates after
latrunculin A treatment. (j–l) Incubation of podocytes with lower concentration of latrunculin A leads to the disruption of stress fibers only in
some podocytes. The podocyte not expressing f-pdlim2 (arrow) shows no stress fibers and retracted cell morphology. Instead, the podocyte
positive for f-pdlim2 (green) shows intact stress fibers and maintains normal-appearing cell morphology.
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which we detected pdlim2. The transfected amotl1 coloca-
lized with f-pdlim2 in stress fibers of podocytes using
immunofluorescence staining (Figure 5b). In the glomerulus,
the immunoreactivity for amotl1 colocalized with that of
nephrin (Figure 5b), which, on the other hand, colocalized
with pdlim2 (Figure 2a–f).
Next, we analyzed the association of pdlim2 with a-
actinin-4 by co-immunoprecipitation experiments. HEK293
cells were transfected with f-pdlim2 and ha-tagged a-actinin-
4 (ha-a-actinin-4). As controls, we used irrelevant expression
constructs (myc-gadd45a and MD-2). Immunoprecipitation
of f-pdlim2 with anti-flag antibody co-immunoprecipitated
ha-a-actinin4 in double-transfected cells, whereas no ha-a-
actinin-4 was detected in the control immunoprecipitation
(Figure 5a). Conversely, anti-ha antibody co-immunopreci-
pitated f-pdlim2, whereas the control immunoprecipitation
did not bring down f-pdlim2 (Figure 5a). The analysis of cell
lysates showed expression of recombinant proteins in both
Table 1 | Effect of pdlim2 to podocyte stress fiber stability
under latrunculin A treatment
F-pdlim2– (%) F-pdlim2+ (%)
Latrunculin A
1.0mmol/l 75.3±7.5 87.9±3.5*
3.0mmol/l 14.9±4.8 46.3±6.9*
5.0mmol/l 1.3±1.2 3.3±2.3 (NS)
Abbreviations: F-pdlim2, flag-tagged pdlim2; NS, not significant (in comparison with
f-pdlim2– cells). Differentiated podocytes were transfected with f-pdlim2, and
transfected cells (f-pdlim2+) were compared with non-transfected cells (f-pdlim2–).
The results are shown as percent (±s.d.) of cells that have intact stress fibers.
*Po0.05 (in comparison with f-pdlim2– cells).
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Figure 5 |Analysis of interaction of pdlim2 with a-actinin-4 and angiomotin-like-1 (amotl1). (a) Immunoprecipitation (IP) of double
transfected cells with anti-flag antibody brings down ha-tagged a-actinin-4 (ha-actn4) together with flag-tagged pdlim2. Control
experiments do not bring down ha-a-actinin-4. IP with anti-ha antibody co-immunoprecipitates flag-pdlim2, whereas the control IP with a
non-related expression construct does not bring down flag-pdlim2. Input lysates from these experiments show expression of recombinant
proteins. (b) Transfected pdlim2 (f-pdlim2, green) colocalizes (yellow) with amotl1 (red) in filamentous intracellular structures (stress fibers)
in cultured podocytes. In the glomerulus, staining for amotl1 overlaps partially with that of nephrin as a linear line along capillary loops.
IP of double-transfected cells with anti-flag antibody brings down amotl1 together with flag-pdlim2, whereas control IPs with a control
construct does not bring down amotl1. Conversely, IP with anti-amotl1 antibody co-immunoprecipitates flag-pdlim2, whereas control
experiments do not bring down flag-pdlim2. Input lysates from these experiments show expression of recombinant proteins.
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experiments (Figure 5a). Of note, both a-actinin-4 clones
identified in the y2h screen were from the C-terminal part of
the protein (cDNA sequences encoding for amino acids
866–912 and 830–912). Thus, a-actinin-4 residues 866–912
seemed to be sufficient for the interaction with pdlim2.
The association of amotl1 with pdlim2 was confirmed
by transfecting HEK293 cells with f-pdlim2 and amotl1
constructs, followed by co-immunoprecipitation. Immuno-
precipitation of f-pdlim2 with anti-flag antibody co-immu-
noprecipitated amotl1 in double-transfected cells, whereas no
amotl1 was detected in the control immunoprecipitation
(Figure 5b). Conversely, immunoprecipitation with anti-
amotl1 antibody brought down f-pdlim2, whereas control
immunoprecipitation experiments did not co-immunopreci-
pitate f-pdlim2 (Figure 5b). The analysis of cell lysates
showed expression of recombinant proteins in both experi-
ments (Figure 5b).
Pdlim2 expression in human proteinuric diseases
As the organization of the foot process actin cytoskeleton is
significantly altered in proteinuric processes, we investigated
the expression of pdlim2 by semiquantitative immunoelec-
tron microscopy in three common causes of nephrotic
syndrome in humans: minimal change nephrotic syndrome
(MCNS), membranous nephropathy (MN), and focal
segmental glomerulosclerosis (FSGS). The amount of albu-
minuria and the degree of foot process effacement in disease
groups was not significantly different (Table 2).
In patients with MCNS, MN, and FSGS, the labeling for
pdlim2 localized specifically to foot processes by immunoe-
lectron microscopy (Figure 6a–d). The semiquantification of
pdlim2 expression showed that in patients with MN and
MCNS, the expression was significantly decreased (to
approximately one-third), whereas in patients with FSGS
the labeling frequency was unchanged compared with
controls (Table 2). Thus, pdlim2 expression was decreased
specifically in patients with MCNS and MN, but this did not
seem to be a general phenomenon for proteinuria and foot
process effacement.
DISCUSSION
We have identified pdlim2 as a novel actin-regulating protein
of podocyte foot processes. In the kidney, pdlim2 was
expressed exclusively by podocytes, in which it colocalized
with the actin cytoskeleton of foot processes. Similar
podocyte-specific expression pattern has been previously
described for proteins that are essential for the glomerular
filtration barrier, such as nephrin, podocin, and synaptopo-
din.18–20 This exclusive expression pattern suggests that
pdlim2 may also have an important role in these specialized
epithelial cells of the glomerulus.
We investigated the role of pdlim2 in podocytes using cell
culture. As pdlim2 was not expressed endogenously in
cultured podocytes, we introduced pdlim2 to cultured
podocytes by transfection. The transfected pdlim2 protein
was targeted to stress fibers and cortical actin. After the
disruption of stress fibers with latrunculin A, a chemical that
disrupts the actin cytoskeleton by inhibiting polymerization
of actin monomers, pdlim2 colocalized with actin in
cytoplasmic aggregates. This supports our findings in
immunoelectron microscopy that suggested pdlim2 to be
associated with the actin cytoskeleton. As we titrated down
the latrunculin A concentration in cell culture media, we
observed that stress fibers in pdlim2-expressing podocytes
were more resistant to this treatment than stress fibers in
Table 2 | Summary of semiquantitative immunoelectron
microscopy data
Group Albuminuria (g/day) Slits/lm Au/lm2
Controls (n=6) NM 2.4±0.6 19.5±8.7
MN (n=5) 6.0±3.7 (NS) 0.3±0.3*,a 6.7±2.6**
MCNS (n=5) 9.1±2.7 (NS) 0.6±0.2*,a 6.4±3.6**
FSGS (n=4) 3.0±1.7 (NS) 0.3±0.2*,a 19.7±7.9
Abbreviations: FSGS, focal segmental glomerulosclerosis; MCNS, minimal change
nephrotic syndrome; MN, membranous nephropathy; NM, not measured (collected
from patients with neoplasia, no known proteinuria); NS, no significant difference in
proteinuria between MN, MCNS, and FSGS patients.
aNo significant difference between MN, MCNS, and FSGS samples.
*Po0.05 (in comparison with controls).
**Po0.05 (in comparison with controls and FSGS).
The amount of albuminuria at the time of biopsy (g/day), the degree of foot process
fusion (slits/mm), and the labeling intensity for pdlim2 (Au/mm2) are shown. Slits/mm
indicates the frequency of podocyte filtration slits/glomerular basement membrane
(GBM) length and Au/mm2 the number of gold label for pdlim2/foot process area.
GBM
GBM GBM
MN
D
MCNS
GBM
Normal FSGS
Figure 6 | Expression of pdlim2 in patients with focal
segmental glomerulosclerosis (FSGS), membranous
nephropathy (MN), and minimal change nephrotic syndrome
(MCNS) as detected by immunoelectron microscopy. (a) In the
control podocyte, a frequent labeling for pdlim2 is observed in
foot processes. (b) In patients with FSGS, an abundant labeling for
pdlim2, similar to that seen in controls, is observed despite
extensive foot process effacement. (c, d) In contrast to this,
labeling for pdlim2 (arrowheads) is significantly decreased in
patients with MCNS and MN. Arrowhead, gold marker; D, immune
deposition; GBM, glomerular basement membrane. Scale
bar¼ 1 mm.
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pdlim2-deficient cells. Thus, pdlim2 stabilized actin struc-
tures in cultured podocytes. As this stabilizing effect was also
observed in undifferentiated podocytes, it may be that this
phenomenon is not specific only for podocytes. Pdlim2 is a
member of the ALP superfamily of proteins that are
characterized by N-terminal pdz domain and C-terminal
lim domain, and that are thought to associate with actin.21
This is the first time a member of the ALP superfamily is
shown to be present in podocytes. Pdlim2 may be needed for
the robust regulation of foot process actin cytoskeleton that is
known to be critical for the maintenance of the glomerulus
filtration barrier.8
To link pdlim2 to the molecular machinery of podocyte
foot processes, we performed y2h screen. In this screen, a-
actinin-4 was identified, and this association was confirmed
by co-immunoprecipitation experiments. These results are in
line with a previous study showing that pdlim2 can interact
with various a-actinins.14 Mutations in a-actinin-4 have been
shown to cause FSGS.22 Mutated a-actinin-4 have a higher
affinity for actin than the normal a-actinin-4, and in that way
results in dysfunction of foot process cytoskeleton, foot process
effacement, and proteinuria.23 Pdlim2 may have a role in these
disease processes as it directly interacts with a-actinin-4 and
regulates actin dynamics in podocytes. We have tried to clarify
the functional relationship between a-actinin-4 and pdlim2 by
using a-actinin-4 knockout podocytes (generated previously
by Dandapani et al.24), and it seems that the effects of
pdlim2 on the actin cytoskeleton are not dependent on
a-actinin-4 (L Sistani et al., unpublished data).
Amotl1 was also identified in the y2h screen with pdlim2.
We confirmed this interaction using co-immunoprecipitation
experiments. Amotl1 was detected in podocyte foot processes
by immunofluorescence staining, and this is the first time
amotl1 has been identified in podocytes. Previously, amotl1
has been shown to control endothelial cell polarity and
cell–cell junction stability.25 In addition, amotl1 has been
shown to associate with actin and modify the architecture of
actin cytoskeleton.12 Amotl1 can have a similar function in
podocytes and may, together with pdlim2, govern the
dynamics of the actin cytoskeleton in foot processes.
To investigate the involvement of pdlim2 in human
proteinuric diseases, we analyzed the expression of pdlim2 in
renal biopsies collected from patients with MN, MCNS, and
FSGS. Semiquantitative immunoelectron microscopy showed
a significant decrease in pdlim2 expression (approximately
decreased to one-third) in patients with MN and MCNS, but
not in patients with FSGS. This differential expression of
pdlim2 in the disease groups was surprising as the patients
did not show significant difference in the degree of
proteinuria or foot process fusion. Thus, the decreased
expression of pdlim2 in MN and MCNS patients does not
seem to be only secondary to proteinuria or foot process
effacement. Obviously, more studies on the role of pdlim2 in
the pathogenesis of proteinuric diseases are needed.
MCNS and FSGS are two common causes of nephrotic
syndrome in pediatric patients.26 MCNS usually has a good
prognosis and most patients respond to steroid therapy.
FSGS usually has a more progressive nature and additional
immunosuppressive therapy is often needed. Therefore, the
differential diagnosis between the two disorders is critical.
However, because of the focal nature of diagnostic sclerotic
lesions in FSGS, the differential diagnosis between MCNS
and FSGS is sometimes difficult.26 Our finding that the
expression of pdlim2 in podocytes is decreased in MCNS but
not in FSGS suggests that pdlim2 could be a useful diagnostic
marker for differentiating the two diseases. Our observation
should, however, be tested in a larger study.
To summarize our results, we have identified pdlim2 as a
novel actin-regulating molecule of podocyte foot processes.
Pdlim2 interacts with a-actinin-4 and amotl1, the two known
regulators of actin assembly. The expression of pdlim2 is
decreased in patients with MCNS but not in patients with
FSGS, which makes it a potential candidate as a molecular
marker in the differential diagnosis of these two diseases.
MATERIALS AND METHODS
Reverse transcriptase-PCR
Reverse transcriptase-PCR experiments were performed using
standard procedures. The following pdlim2 primer sequences were
used: left 50-ATGGCGTTGACTGTGGATGT-30, and right 50-TCAG
GCTCGAGAGTTGAGAG-30. Podocin and GAPDH primers were
used in control reactions.
Production of anti-pdlim2 antibodies
Residues 87–212 for the human pdlim2 protein were expressed and
purified. Antibodies were raised by an immunization of a New
Zealand White rabbit, and obtained serum was used for purification
of monospecific antibodies. The specificity of the pdlim2 antibody
was confirmed by transfecting HEK293 cells with pdlim2 and
nephrin constructs. These cells were prepared for immunofluores-
cence staining and western blotting according to standard
procedures.
Western blotting
Western blotting experiments were performed according to standard
procedures by comparing isolated glomerular tufts and the kidney
extract lacking glomeruli. As a control, we immunodetected b-actin
with an anti-b-actin antibody (Abcam, Cambridge, UK). Samples
were obtained from cadaver kidneys unsuitable for transplantation
because of vascular abnormalities. The study was approved by the
local ethics committee.
Immunofluorescence
Immunofluorescence stainings were performed as described pre-
viously.27 Double-labeling experiments were performed with a
monoclonal anti-synaptopodin antibody (Progen, Heidelberg,
Germany), a monoclonal anti-vimentin antibody (Zymed Labora-
tories, San Francisco, CA), and rhodamine-labeled phalloidin.
Immunoelectron microscopy
Immunoelectron microscopy was performed as described pre-
viously.28 In the double-labeling experiment, goat anti-rabbit
(10 nm) and goat anti-mouse (5 nm) antibodies were used to detect
pdlim2 and synaptopodin, respectively. The labeling was analyzed in
three glomeruli (if available) from each specimen. Ten different areas
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were chosen randomly at low magnification where no gold markers
can be detected. Thereby, a biased selection of fields for counting
gold particles could be avoided. In each area, one image was taken at
higher magnification, and in total 20–30 images were taken on each
biopsy. Printed copies were examined at  52,000, and podocyte
cytoplasm area within 3 cm (B1 mm) from the glomerular basement
membrane was measured by the point-counting method. The
number of gold particles within the same zone was counted. The
concentration of pdlim2 was expressed as the number of gold
markers per square micrometers (Au/mm2). The glomerular base-
ment membrane length and the number of slits were expressed as a
ratio (Slits/mm) to evaluate foot process effacement. The material
was analyzed using one-way analysis of variance and groups were
compared using Tukey’s HSD (Honestly Significant Difference) test
for unequal n. Po0.05 was considered significant.
For semiquantitative immunoelectron microscopy on renal
biopsies, patients fulfilling the clinical and histopathological criteria
for MCNS, MN, and FSGS were chosen. All cases were reviewed
histologically. Data on proteinuria at the time of biopsy were
collected (Table 2). As control tissue, normal portions of kidneys
resected due to localized neoplasia were used.
Pdlim2 in cultured podocytes
The endogenous expression of pdlim2 in cultured podocytes was
studied with western blotting and immunofluorescence staining. We
used one mouse15 and one human podocyte cell line.16 As we did
not detect endogenous pdlim2 expression in podocytes, human
podocytes were transfected with flag-tagged pdlim2 using Lipofec-
tamine (Sigma, St Louis, MO, undifferentiated podocytes) and
Amaxa Nucleofactor (Lonza, Basel, Switzerland) (differentiated
podocytes). The cells were stained for flag, phalloidin, and 4,6-
diamidino-2-phenylindole. As a control, we used untransfected or
cells transfected with a pcDNA-nephrin construct.
Latrunculin A treatment
The cytoskeleton was disrupted using an actin monomer-sequester-
ing drug latrunculin A. Undifferentiated and differentiated podo-
cytes were transfected with f-pdlim2 48 h before the addition of
latrunculin A. After initial titration experiments, latrunculin A was
added to cell culture media in three different concentrations (1.0,
3.0, and 5.0 mmol/l) and incubated for 30min. Latrunculin A was
then washed away with phosphate-buffered saline and the cells were
prepared for immunofluorescence staining. The cells were stained
for flag, phalloidin, and 4,6-diamidino-2-phenylindole. The effect of
latrunculin A was evaluated by comparing the proportion of cells
with intact stress fibers in pdlim2-positive and pdlim2-negative cells.
A minimum of 100 cells were analyzed in each experiment and every
experiment was repeated at least three times.
Adhesion assay
Differentiated podocytes were transfected with f-pdlim2 24 h before
the adhesion assay. Podocytes were harvested with trypsin/EDTA
and resuspended in serum-free medium. Cells were allowed to
attach on collagen I or fibronectin-coated plates at 37 1C for 15min,
30min, 60min, or 18 h. Unbound cells were removed, and attached
cells were fixed in paraformaldehyde, and stained for flag.
Proportion of attached f-pdlim2-positive cells were calculated at
each time point in at least 200 cells in each experiment. The
proportion of pdlim2-positive cells was compared with the control
time point (18 h), which indicated transfection efficiency. Each
experiment was repeated three times.
Yeast two-hybrid assay
The coding sequence of mouse pdlim2 in a bait plasmid pGBKT7
(Clontech Laboratories, Mountain View, CA) was mated with a prey
library that was generated from the mouse glomerulus RNA. The
screening was performed using reporter genes mel1, HS3, and ADE3.
Clones positive for this triple selection were sequenced using
standard technology.
Co-immunoprecipitation
The interaction of pdlim2 with a-actinin-4 and amotl1 was
confirmed with co-immunoprecipitation experiments. HEK293 cells
were co-transfected with flag-tagged pdlim2 together with either
ha-a-actinin-4 or (untagged) amotl1 construct. As controls we used
irrelevant expression constructs (myc-tagged gadd45a and MD-2).
Immunoprecipitations were performed according to standard
procedures.
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